Pieris Pharmaceuticals Stock Market Value
| PIRS Stock | USD 0.16 0.01 5.88% |
| Symbol | Pieris |
Pieris Pharmaceuticals Price To Book Ratio
Is Pieris Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pieris Pharmaceuticals. If investors know Pieris will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pieris Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.27) | Revenue Per Share 0.475 | Quarterly Revenue Growth (0.78) | Return On Assets (0.15) | Return On Equity (0.90) |
The market value of Pieris Pharmaceuticals is measured differently than its book value, which is the value of Pieris that is recorded on the company's balance sheet. Investors also form their own opinion of Pieris Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Pieris Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pieris Pharmaceuticals' market value can be influenced by many factors that don't directly affect Pieris Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pieris Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pieris Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pieris Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Pieris Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pieris Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pieris Pharmaceuticals.
| 04/23/2023 |
| 04/17/2024 |
If you would invest 0.00 in Pieris Pharmaceuticals on April 23, 2023 and sell it all today you would earn a total of 0.00 from holding Pieris Pharmaceuticals or generate 0.0% return on investment in Pieris Pharmaceuticals over 360 days. Pieris Pharmaceuticals is related to or competes with Adaptimmune Therapeutics, Mereo BioPharma, PDS Biotechnology, Leap Therapeutics, X4 Pharmaceuticals, Corvus Pharmaceuticals, and Terns Pharmaceuticals. Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anticalin-based drugs More
Pieris Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pieris Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pieris Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.11 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 33.53 | |||
| Value At Risk | (5.88) | |||
| Potential Upside | 6.25 |
Pieris Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pieris Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pieris Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Pieris Pharmaceuticals historical prices to predict the future Pieris Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0119 | |||
| Jensen Alpha | (0.01) | |||
| Total Risk Alpha | (0.37) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0349 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pieris Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Pieris Pharmaceuticals Backtested Returns
We consider Pieris Pharmaceuticals dangerous. Pieris Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.0042, which implies the firm had a 0.0042% return per unit of risk over the last 3 months. We have found thirty technical indicators for Pieris Pharmaceuticals, which you can use to evaluate the volatility of the company. Please check Pieris Pharmaceuticals' Coefficient Of Variation of 20012.02, semi deviation of 3.25, and Risk Adjusted Performance of 0.0119 to confirm if the risk estimate we provide is consistent with the expected return of 0.0209%. The company holds a Beta of 0.43, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Pieris Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Pieris Pharmaceuticals is expected to be smaller as well. Pieris Pharmaceuticals right now holds a risk of 5.0%. Please check Pieris Pharmaceuticals sortino ratio and the relationship between the semi variance and relative strength index , to decide if Pieris Pharmaceuticals will be following its historical price patterns.
Auto-correlation | 0.69 |
Good predictability
Pieris Pharmaceuticals has good predictability. Overlapping area represents the amount of predictability between Pieris Pharmaceuticals time series from 23rd of April 2023 to 20th of October 2023 and 20th of October 2023 to 17th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pieris Pharmaceuticals price movement. The serial correlation of 0.69 indicates that around 69.0% of current Pieris Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.69 | |
| Spearman Rank Test | 0.6 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Pieris Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Pieris Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Pieris Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Pieris Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Pieris Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Pieris Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Pieris Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Pieris Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Pieris Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Pieris Pharmaceuticals Lagged Returns
When evaluating Pieris Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Pieris Pharmaceuticals stock have on its future price. Pieris Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Pieris Pharmaceuticals autocorrelation shows the relationship between Pieris Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Pieris Pharmaceuticals.
Regressed Prices |
| Timeline |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Pieris Pharmaceuticals using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Pieris Pharmaceuticals Correlation, Pieris Pharmaceuticals Volatility and Pieris Pharmaceuticals Alpha and Beta module to complement your research on Pieris Pharmaceuticals. For more information on how to buy Pieris Stock please use our How to Invest in Pieris Pharmaceuticals guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Complementary Tools for Pieris Stock analysis
When running Pieris Pharmaceuticals' price analysis, check to measure Pieris Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pieris Pharmaceuticals is operating at the current time. Most of Pieris Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pieris Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pieris Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pieris Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
Pieris Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.